neog - Neogen's E.Coli Test adopted by Japan Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan

NEOG 6.410

+7.2%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ken Sims who wrote (20)	9/4/1997 6:51:00 PM
From: janet kuhnert	of 441

I had some correspondence with Neogen Investor Relations. They were prompt and clear in responding to my questions. 1) They felt they were thinly traded because many of their stockholders are long term. The stock is trading higher because of interest, as their E.coli 0157-H7. 2) They have been trying to get into the larger brokerages, but with only 6.1 million shares, they are small. 3) The sales force sells to and trains the distributors, and they sell to individual processors internationally. In US the sales force sells directly to the users of their product. That would be the food processors and the testing labs. 4) They have about 50 people involved in sales and marketing of diagnostic testing products. They do not use outside sales people. They also have a coporate video that is available. Their web site, www.neogen.com, is clear and easy to manuver. JK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next